Skip to main content

Table 2 The short-term efficacy of Group D1 and Group D2

From: Current status of neoadjuvant therapy for locally advanced rectal cancer in Wuhan Union Hospital Cancer Center

  Group D1 (n = 37) Group D2 (n = 61) P value
No. of patients % No. of patients %  
pCR 8 21.6 30 49.2 0.007
T-stage decreased 22 59.5 49 80.3 0.025
N-stage decreased 26 70.3 46 75.4 0.576
R0 resection 0 100.0 1 1.6 -
  1. Abbreviations: pathological complete response